The way I think of weight loss medications, in general, is as helpers to the lifestyle change approach
NAION usually leads to damage that the doctor cannot fix, even if it is found quickly
Tirzepatide patients lost an average of 20.2% of their body weight, while semaglutide patients lost 13.7%, a difference of 6.5 percentage points.[1] In practical terms, for someone starting at 250 pounds, that means losing roughly 50 pounds (22.8 kg) on tirzepatide versus 33 pounds (15.0 kg) on semaglutide.[1] Waist circumference shrank by an average of 7.2 inches (18.4 cm) with tirzepatide versus 5.1 inches (13.0 cm) with semaglutide, a difference with real implications for heart disease risk.[1] When researchers looked at more dramatic weight loss thresholds, tirzepatide pulled further ahead
Examples Sitagliptin (Januvia) Dosage Initial: 25100 mg once daily (depending on kidney function) Maximum: 100 mg once daily Saxagliptin (Onglyza) Dosage Initial: 2.55 mg once daily Maximum: 5 mg once daily Linagliptin (Tradjenta) Dosage Initial: 5 mg once daily Maximum: 5 mg once daily Alogliptin (Nesina) Dosage Initial: 6.2525 mg once daily (depending on kidney function) Maximum: 25 mg once daily Possible side effects include: Acute pancreatitis (this appears to be rare) Severe joint pain Thiazolidinediones (TZDs) Primary mechanism(s) of action Modulation of glucose and lipid metabolism via activation of the PPAR-gamma nuclear hormone receptor
Will I have to do phone or video appointments
